1. Home
  2. KGS vs SYRE Comparison

KGS vs SYRE Comparison

Compare KGS & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kodiak Gas Services Inc.

KGS

Kodiak Gas Services Inc.

HOLD

Current Price

$62.15

Market Cap

3.5B

Sector

N/A

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$69.74

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KGS
SYRE
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.0B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
KGS
SYRE
Price
$62.15
$69.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
12
Target Price
$55.67
$82.50
AVG Volume (30 Days)
1.0M
1.0M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
3.18%
N/A
EPS Growth
58.93
N/A
EPS
0.89
N/A
Revenue
$1,308,100,000.00
N/A
Revenue This Year
$11.61
N/A
Revenue Next Year
$7.81
N/A
P/E Ratio
$69.24
N/A
Revenue Growth
12.83
N/A
52 Week Low
$30.06
$12.29
52 Week High
$63.62
$75.00

Technical Indicators

Market Signals
Indicator
KGS
SYRE
Relative Strength Index (RSI) 69.05 84.30
Support Level $56.51 $15.23
Resistance Level N/A N/A
Average True Range (ATR) 1.67 4.18
MACD 0.08 2.07
Stochastic Oscillator 79.75 82.25

Price Performance

Historical Comparison
KGS
SYRE

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: